GCC sector
Healthcare, Pharma & Life Sciences GCCs
Pharma, biopharma, medtech and healthcare providers are building India centres for technology, data science, clinical operations and commercial analytics. We help them build compliant data platforms, govern AI and automate document-heavy work.
From clinical data to commercial analytics, safely
What these centres own
Life-sciences centres typically span digital and IT, data science and analytics, clinical data management, regulatory and pharmacovigilance operations, and commercial analytics. Healthcare-provider centres add revenue-cycle, care-operations and health-technology engineering.
What's specific to this sector
Health data carries HQ-jurisdiction obligations (HIPAA, GDPR) as well as India’s DPDP Act, and regulated processes expect validated systems and traceable change. Auditable access logs, encrypted storage, documented retention and validation evidence are guardrails we configure at the start.
Our team has built health-data platforms, EHR integrations and consent-aware data layers on HL7/FHIR standards.
Where these centres cluster
Compare cities in the GCC City Index →How we help Life sciences centres
Validated-environment platforms
Data and ML platforms with access controls, audit trails and change records that support GxP-style validation, rather than a platform that has to be re-validated after the fact.
Document-heavy automation
Agents for literature review, safety-case intake, regulatory document assembly and medical-information queries, always with qualified humans signing off.
Privacy by design
Patient-level data handled under HIPAA-grade controls and the DPDP Act, with consent and purpose limitation enforced in the data layer.
The services these centres use most
Recent Life sciences GCC moves in India
From our India GCC Tracker. Every row links to its source.
| Company | City | Mandate | Scale | Year | Source |
|---|---|---|---|---|---|
| Amgen | Hyderabad | New science and innovation (research) centre joining Amgen's global network of research labs | ~200 highly skilled professionals; operations expected 2027 | 2027 | Global Healthcare Magazine |
| Amgen | Hyderabad | Amgen India technology and innovation site - AI and data science for drug development plus global business solutions | Initial USD 200m in 2025; ~300 staff at Feb 2025 opening, ~2,000 targeted by end-2025 | 2025 | ThePrint (Reuters) |
| Eli Lilly | Hyderabad | Lilly Capability Centre India (LCCI) Hyderabad - automation, AI, software product engineering and cloud for Lilly's global business | 1,000-1,500 professionals planned; ~100 onboarded at August 2025 opening; 220,000 sq ft in Phoenix Equinox, Gachibowli | 2025 | Indian Pharma Post |
| HCA Healthcare | Hyderabad | First India GCC (Global Capability Network) for IT, supply chain, procurement, finance and HR, expanding into AI and data-driven operations | USD 75m investment; ~1,100 employees at launch, targeting 3,000 by end-2026; ~428,000 sq ft | 2025 | CIO Bulletin |
| Bristol Myers Squibb | Hyderabad | Innovation hub for global drug development, IT and digital capabilities | USD 100m+ investment; 1,500+ employees expected | 2024 | Indian Pharma Post |
Further reading
From Support Centre to AI Owner: Agentic Automation Inside GCCs
HQ wants India to lead AI while the GCC absorbs manual work. Where agentic automation fits, function by function, and how to go from PoC to programme.
AI Governance for GCCs: Control Planes, Evals and Audit Trails
How India GCCs can lead AI without becoming the company's biggest AI risk: an AI control plane, evaluation suites, audit trails and DPDP Act obligations.
Automated Compliance Checks That Scale
What automated compliance guardrails actually look like in a CI/CD pipeline for fintech, healthcare, and payments — concrete checks, not policy documents.
Questions about Life sciences GCCs
Why are so many pharma GCCs in Hyderabad?
Hyderabad combines a deep life-sciences industrial base, a large technology talent pool and active state promotion, which has made it the default first choice for many pharma and healthcare centres.
Can AI be used in pharmacovigilance or regulatory work?
As assistance with human sign-off: intake triage, literature screening and document drafting, with evaluations, audit trails and qualified reviewers making the decisions.
How do you handle patient data in an India centre?
De-identification by default, access logging on every read, encryption at rest and in transit, and consent and purpose limits enforced in the data layer, mapped to HQ and DPDP obligations.
Building a Life sciences centre in India?
Tell us your stage and city. We'll bring a view on what centres like yours typically need next, and which of it we'd deliver versus source.
We reply with proposed call slots within one business day.